AMD 3465 (*Hexahydrobromide*) Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
AMD 3465 is a CXCR4 antagonist and in combination with monoclonal antibody, was shown to be potentially effective in reducing tumor growth and increasing survival in patient with B cell lymphoma
Biochem/physiol Actions
AMD3465 is also termed as{N-[1,4,8,11-tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-2-(aminomethyl)pyridine}. It controls oncogenic signaling and invasiveness in vitro. It inhibits breast cancer growth and metastasis in vivo. As a chemokine receptor 4 (CXCR4) antagonist, AMD3465 is ten times more efficient than bicyclam AMD3100.
AMD 3465 (*Hexahydrobromide*) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte